I’ve been noticing a specific kind of selfie lately. The person in it has clearly lost a significant amount of weight. Their cheekbones are sharp, their jawline defined. And yet something looks off—in the way that makes you tilt your head slightly and wonder if they’re sleeping okay. The eyes look sunken. The skin seems like it’s been stretched loose over a smaller frame it wasn't expecting to inhabit.
This is what people are calling “Ozempic face”. And with GLP-1 medications—semaglutide (Ozempic, Wegovy), tirzepatide (Mounjaro)—making rapid weight loss more accessible than ever, that selfie is showing up more and more in dermatology waiting rooms across India and the world.
What’s actually happening under the hood
Here’s the thing about your face: it is not just skin. Under it lives a complex architecture of fat pads, collagen, and bone. The fat pads are the supporting cast—they keep everything lifted, plump, and in its correct spatial relationship with everything else.
When you lose weight quickly on GLP-1 medications, those fat pads shrink. Faster, more often, than the skin above them can reorganise. “When fat is lost quickly, the skin often lacks the elasticity to snap back at the same rate, leading to dermal laxity, deepening of the nasolabial folds, and a gaunt appearance,” explains Dr Kiran Sethi, founder of Isya Aesthetics in Delhi. “From a clinical perspective, Ozempic face is the result of rapid subcutaneous fat atrophy and the depletion of facial fat pads that provide the structural scaffolding for our skin.”
According to Dr Sonali Kohli, senior consultant in Dermatology at Sir HN Reliance Foundation Hospital, the hollows, the deepened lines, the jawline that suddenly seems less defined—none of these are side effects of the medication itself. “It is not a condition,” she says. “It is just what happens when you lose weight quickly.” When the fat recedes, the bones start to show more, and that reads, to most eyes, as ageing.
Do the drugs affect collagen and skin quality? Dr Jaishree Sharad—a Mumbai-based board-certified cosmetic dermatologist—is careful here. “There is no scientific study, like evidence-based or randomised controlled studies, which talk about direct effects of GLP-1 on skin quality, collagen production, or hydration,” she says. Theoretically, though, fibroblasts (the cells that produce collagen) have GLP-1 receptors on them—which means there’s theoretical potential for effects like oxidative stress (ageing) and collagen degradation. “We still don’t have any evidence over there,” Dr Sharad reiterates. The honest answer is: we don’t fully know yet.
What we do know is that rapid weight loss can reduce the nutrients available to your skin, like protein and healthy fats, and increase systemic stress. This is what is apparent on the face.
A new brief
“Clients aren’t walking in asking about fine lines anymore. They’re asking why their lower face looked ‘deflated’ or why their jawline had lost definition almost overnight. That’s a fundamentally different brief for product development,” says Dr Renita Rajan, founder of skincare label Chosen by Dermatology. Brands still building products around wrinkle reduction are, she feels, “answering yesterday’s question”.
Another notable change is the demographic. Structural facial concerns, like jowling, volume loss, and lower-face laxity, were, until recently, the territory of patients in their fifties. Now Dr Rajan is seeing them in people in their thirties.
The younger patients are also coming in armed with a lot of information, a shift Dr Sharad finds interesting. “People are coming to us in the beginning itself,” she says. They’re trying to prevent the signs of GLP-1s showing on their face rather than fix the damage after it’s done.
This is perhaps the most significant behavioural shift this trend has generated: the idea of preemption.
Dr Sethi calls it “collagen banking”, which is beginning treatments to stimulate collagen production before the weight loss happens, so that when fat does recede, the skin has the structural reserves to handle it. Her protocol involves gradual weight loss (losing more than 1 kg per week, she says, increases the risk of “skin-fat mismatch”), adequate protein intake, strength training, and early clinical intervention as soon as month one or two of a weight loss journey.
Dr Kohli confirms this has become standard advice. “People who know they will be losing a lot of weight are starting treatments to stimulate collagen before they lose weight, getting treatments to tighten their skin before it gets loose.”
Treatments, too, have evolved from being filler-forward to biostimulatory. “We are moving away from filling in the fat that is lost to actually rebuilding the structure of the face,” says Dr Kohli. Prescriptions now include Sculptra and Profhilo (which encourage the body’s own collagen production), micro-focused ultrasound, like Ultherapy (which targets deeper layers of the face before significant sagging sets in), microneedling with radiofrequency, and polynucleotides—DNA fragments that offer “true regenerative potential at a cellular level”, according to Dr Sethi.
Fillers haven’t disappeared; they’re just lower on the rung now. Dr Sharad uses them judiciously. Her protocol involves: “Just a little bit of filler, and then you top it with a biostimulator to maintain it.” The word she uses repeatedly is “planned”. Nothing about this is reactive anymore. And for the most significant cases of volume loss (typically in patients over 45 or those who have lost a large amount of weight), she refers out entirely. “In those scenarios, I’ll send the patient to my plastic surgeon colleague to do a fat graft.” She has been incorporating newer treatments like microneedling with PDRN as well as microneedling with exosomes, both of which work at the level of skin elasticity and cellular regeneration rather than just surface texture. They are being used specifically to improve skin elasticity and skin quality in patients experiencing volume-related changes. She’s also using a non-ablative erbium hybrid CO2 laser, one she describes as particularly effective for building collagen and firming skin along the face and neck.
The skincare shelf is rethinking itself, too
Dr Rajan thinks the word that will define the next five years of skincare is resilience. “Plumping is a temporary aesthetic; density and resilience speak to skin’s underlying capacity to hold its shape.” Her brand, Chosen, developed the Sculpt Serum with DMAE, OptiMSM, and retinol, specifically to address lower-face contour changes. It’s formulated, she says, with clinical data behind it rather than buzzwords in front of it.
At home, patients are being directed toward ingredients that repair and protect rather than just decorate: ceramides, omega fatty acids, and cholesterol to rebuild the skin barrier; peptides and growth factors to signal collagen production; hyaluronic acid and glycerin for hydration.
Retinoids remain foundational, though Dr Sethi notes they need to be balanced with ceramides when the skin is in a state of “systemic metabolic shifts”. Dr Sharad adds vitamin C to that foundational stack for collagen support alongside the retinoids and peptides, with the logic being that you’re not just treating the surface, you’re also trying to slow what’s happening underneath it.
The real paradox is, as Dr Sharad observes, “You want the body to be slim, but you want the face to be fuller.” The medication achieves exactly what people asked it to. And then people arrive at the dermatologist wanting to undo what the medication did—but only to one part of the body.
Skin sagging and jowls as are par for the course as we age. Losing weight with Ozempic, Dr Kohli says, “has just sped up the things that happen to our skin naturally”. Which means the question isn’t really about Ozempic at all. It’s about what we want from our body, our face, how fast, and what we’re willing to do—and spend—to get there.
